Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Investor Presentation
Intimation of Q1 FY24 Earnings Presentation29-07-2023
29-07-2023
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rossari Biotech Limited has informed the exchange regarding a Press Release dated July 29, 2023, titled "Rossari Biotech announces Q1 FY24 results"29-07-2023
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Change in Management
Re-Classification of Senior Management Personnel of the Company29-07-2023
Rossari Biotech Ltd - 543213 - Outcome Of Board Meeting Held On Saturday, July 29, 2023
The Board of Directors have inter alia approved Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2023 of the Financial Year 2023-24 and other matters.29-07-2023
Rossari Biotech Ltd - 543213 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, July 29, 2023
The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2023 of the Financial Year 2023-24 and other matters.29-07-2023
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Rossari Biotech Limited has informed the Exchange Regarding Allotment of 71800 Shares.28-07-2023
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of affirmation of Credit Rating26-07-2023
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call for investors and analysts on Monday, July 31, 2023 at 03:30 P.M. IST24-07-2023
Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Inter Alia To Approve The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2023.
Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2023 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023.21-07-2023
Rossari Biotech Ltd - 543213 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulation, 2018 for the quarter ended June 30, 202310-07-2023